Executive Summary

This vulnerability in dawa-pharma-1.0 allows unauthenticated attackers to execute SQL queries on the server. This means attackers can run database commands without logging in, potentially accessing sensitive information and gaining administrative control over the system.

Useful 0 Not Useful 0

Impact Analysis

The impact of this vulnerability includes unauthorized access to sensitive data stored in the database and the possibility for attackers to gain administrative access, which could lead to data breaches, data manipulation, and full system compromise.

Useful 0 Not Useful 0

Compliance Impact

The vulnerability allows unauthenticated attackers to execute SQL queries on the server, accessing sensitive information and potentially gaining administrative access. This unauthorized access to sensitive data could lead to non-compliance with data protection regulations such as GDPR and HIPAA, which require safeguarding personal and health-related information against unauthorized access and breaches. Therefore, exploitation of this vulnerability poses a significant risk to compliance with these standards. [3, 5]

Useful 0 Not Useful 0

Detection Guidance

This vulnerability can be detected by testing the 'email' parameter in POST requests to the dawa-pharma 1.0-2022 application for SQL injection. Example commands include sending payloads that test for Boolean-based blind SQL injection, such as: `email=-8698' OR 5305=5305-- vvuH`, which manipulates the SQL query to always evaluate true. Another method is time-based blind SQL injection using MySQL's SLEEP function to detect delays caused by injected queries. These tests can be performed using tools like curl or SQL injection testing tools targeting the 'email' parameter to confirm if SQL queries are executed. Monitoring for unusual SQL query patterns or unexpected database responses can also help detect exploitation attempts. [5]

Useful 0 Not Useful 0

Mitigation Strategies

Immediate mitigation steps include implementing proper input validation and sanitization on the 'email' parameter to prevent SQL injection. Use prepared statements or parameterized queries in the application code to avoid direct concatenation of user input into SQL queries. Additionally, restrict database permissions to limit the impact of any potential injection. If possible, update or patch the dawa-pharma software to a version that addresses this vulnerability. Monitoring and blocking suspicious requests targeting the 'email' parameter can also help reduce risk until a permanent fix is applied. [3, 5]

Useful 0 Not Useful 0